CC - The Chemours Company

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.04B
Enterprise Value 36.71B
Trailing P/E N/A
Forward P/E 14.72
PEG Ratio (5 yr expected) 1-0.38
Price/Sales (ttm)0.55
Price/Book (mrq)4.41
Enterprise Value/Revenue 31.21
Enterprise Value/EBITDA 620.03

Trading Information

Stock Price History

Beta (5Y Monthly) 2.51
52-Week Change 3-48.48%
S&P500 52-Week Change 321.60%
52 Week High 341.60
52 Week Low 311.71
50-Day Moving Average 316.12
200-Day Moving Average 315.79

Share Statistics

Avg Vol (3 month) 32.79M
Avg Vol (10 day) 34.71M
Shares Outstanding 5163.5M
Float 162.41M
% Held by Insiders 10.86%
% Held by Institutions 180.43%
Shares Short (Jan 30, 2020) 415.83M
Short Ratio (Jan 30, 2020) 46.02
Short % of Float (Jan 30, 2020) 412.86%
Short % of Shares Outstanding (Jan 30, 2020) 49.68%
Shares Short (prior month Dec 30, 2019) 416.37M

Dividends & Splits

Forward Annual Dividend Rate 41
Forward Annual Dividend Yield 46.38%
Trailing Annual Dividend Rate 31.00
Trailing Annual Dividend Yield 35.16%
5 Year Average Dividend Yield 4N/A
Payout Ratio 441.49%
Dividend Date 3Mar 15, 2020
Ex-Dividend Date 4Feb 25, 2020
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin -0.94%
Operating Margin (ttm)1.21%

Management Effectiveness

Return on Assets (ttm)0.57%
Return on Equity (ttm)-6.06%

Income Statement

Revenue (ttm)5.53B
Revenue Per Share (ttm)33.53
Quarterly Revenue Growth (yoy)-7.60%
Gross Profit (ttm)1.06B
EBITDA 335M
Net Income Avi to Common (ttm)-52M
Diluted EPS (ttm)-0.32
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)943M
Total Cash Per Share (mrq)5.75
Total Debt (mrq)4.47B
Total Debt/Equity (mrq)643.31
Current Ratio (mrq)1.80
Book Value Per Share (mrq)4.21

Cash Flow Statement

Operating Cash Flow (ttm)650M
Levered Free Cash Flow (ttm)-370.12M